Clinical and Population Research

Our Clinical and Population Research aims to determine the effectiveness of medications, devices, diagnostic products, and treatments in the field of respiratory illnesses, food allergies, and allergies. We are at the forefront of clinical trials and strive to turn our findings into treatments that will prevent, treat, and relieve patients suffering from respiratory illnesses. To find out about participating in one of our actively enrolling trials, click here

Clinical and Population Trials - Enrolling

Study Title (link to more info on this site)sort ascending Principal Investigator
Vertex 809-110 Cori L. Daines, MD
Vertex 661-108 Cori L. Daines, MD
Vertex 611-110 Cori L. Daines, MD
Trial of Roflumilast in Asthma Management (TRIM) Lynn B. Gerald, PhD, MSPH
Preventing Asthma in High Risk Kids (PARK) Fernando Martinez, MD
PreCISE (Precise Intervention for Severe and/or Exacerbation-Prone Asthma) Network Study Eugene R. Bleecker, MD, Monica Kraft, MD
Optimize Pseudomonas Eradication in Children Cori L. Daines, MD
OM-Pharma Donata Vercelli, MD
Multi-Center Validation of Predictive Sputum Bio-markers in CF (Utah Sputum Study) Cori L. Daines, MD
Microbiome Sputum Study Cori L. Daines, MD
Losartan Effects on Emphysema Progression (LEEP) Lynn B. Gerald, PhD, MSPH, Monica Kraft, MD
Innate Immunity in Asthma (U19) Monica Kraft, MD
Inhaled Mannitol in CF Cori L. Daines, MD
Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH) Lynn B. Gerald, PhD, MSPH, Monica Kraft, MD
IMPACC COVID Monica Kraft, MD
Gossamer: TITAN Tara F. Carr, MD
Gossamer: LEDA Eugene R. Bleecker, MD
Enhanced Single-cell Genomics Tools for Understanding the Temporal Dynamics of Development and Disease (MIRA) Darren A. Cusanovich, PhD
Development of Surfactant Protein A-Derived Peptidomimetics for the Treatment of Asthma Scott Boitano, PhD, Monica Kraft, MD, Julie Ledford, PhD
Cumberland: Aspirin Exacerbation Respiratory Disease (AERD) Tara F. Carr, MD
CC16 COVID Pilot Stefano Guerra , MD, PhD, MPH
BEAMS Paloma Beamer, PhD, Dean Billheimer, PhD, Tara F. Carr, MD, Darren A. Cusanovich, PhD, Fernando Martinez, MD, Donata Vercelli, MD, Anne L. Wright, PhD
B-cell adaptive immune profile in emphysema-predominant COPD Francesca Polverino, MD, PhD
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors Cori L. Daines, MD
(ORBEX) Randomized, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of Oral Bacterial Extract for the prevention of wheezing lower respiratory tract illness Fernando Martinez, MD, Wayne J. Morgan, MD